Opinion: Speaker Pelosi’s Drug Pricing Plan “Crushes the Desperate Hopes of Patients and their Families”
Click here to listen to an interview with BIO President and CEO, Jim Greenwood.
Opinion: Speaker Pelosi’s Drug Pricing Plan “Crushes the Desperate Hopes of Patients and their Families”
Click here to listen to an interview with BIO President and CEO, Jim Greenwood.
Listen to the Onco’Zine Brief hosted by Peter Holfland: A Commitment to Innovation in Medicines, Medical Devices and Healthcare TechnologiesContinue reading
UA Health Sciences Start-up company Regulonix Receives Grant as Part of NIH “Helping to End Addiction Long-Term Initiative” (NIH Heal Initiative).Continue reading
On September 24, 2019, a letter was sent to Congressional Leaders in the Senate and House leadership on behalf of a group of over six hundred innovators, patient groups, physicians, hospitals, venture capitalists and other stakeholders representing millions of patients and hundreds of thousands medical technology jobs, requesting that Congress prioritize repeal of the medical device excise tax before it causes any more harm to the innovation ecosystem. Continue reading
CHANDLER, Ariz. — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that Marti Lindsey, PhD, community engagement director for the Southwest Environmental Health Sciences Center at the University of Arizona College of Pharmacy and the founder and co-director of the KEYS High School Student Internship program at the UA BIO5 Institute, will be honored as the Michael A. Cusanovich Arizona Bioscience Educator of the Year at the AZBio Awards on Oct. 2, 2019.
“Learning opportunities are all around us,” stated Joan Koerber-Walker, president and CEO of AZBio. “Many of these opportunities are thanks to dedicated educators who work to make them engaging, enlightening and memorable. They help us understand the world we live in today and provide tools we can use to shape our tomorrows. Dr. Marti Lindsey is a great example of an educator who is making a difference here in Arizona and across the Southwest region.”Continue reading
Ensuring the proper handling of biological samples used for research is the first step in careful research that meets the necessary high standards of reliability and reproducibility. A new test, which relies on accurate measurement of the relative proportions of two forms of the protein albumin present in blood, was recently described in the journal Molecular and Cellular Proteomics.Continue reading
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that Monica Kraft, MD, professor and chair of the Department of Medicine and The Robert and Irene Flinn Endowed Chair of Medicine at the University of Arizona College of Medicine – Tucson, and deputy director of the UA Health Sciences Asthma and Airway Disease Research Center, will be honored as the Arizona Bioscience Researcher of the Year for her work on precision medicine therapies to treat severe asthma.
Continue reading
Launched by C-Path and NORD through an FDA grant, the goal of the new platform is to accelerate the development of cures by addressing the need to better characterize rare diseases.Continue reading
TEMPE, Ariz.–(BUSINESS WIRE)–INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, to receive up to $5.4 Million over four years as part of the Defense Advanced Research Projects Agency (DARPA) contract worth up to $27.8 Million awarded to consortium led by the Icahn School of Medicine at Mount Sinai New York.Continue reading